OncoSec Medical is a biopharmaceutical company engaged in developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies for the treatment of solid tumor cancers and metastatic disease. Addressing an unmet medical need, OMS ElectroOncology therapies represent a potential solution for less invasive and lower-cost therapies that can minimize the detrimental effects of presently available cancer treatments like surgery, systemic chemotherapy or immunotherapy and other treatment alternatives. For more information, visit the company’s Web site at www.oncosec.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: